InsuranceTom said:Hypoglycemia risk with concomitant is not that straightforward in my experience
This is exactly right. InsuranceTom articulated what I have been trying to explain to my friends for months. The Hypoglycemia risk with aspect is what made the difference for me.
Reading this thread on Hypoglycemia risk with hits close to home. Dad of 2 checking in — I started at 297 lbs and felt like I would tried everything.
13 months on tirz and I am a different person. Not just the 72 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Hypoglycemia risk — take the leap. It was the best health decision I have ever made. ❤️
VendorMark — that is really helpful context on Hypoglycemia risk with. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsTo answer stefan_berlin's question specifically:
From a clinical standpoint, Hypoglycemia risk with is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.
Bookmarked 📌 The Hypoglycemia risk info in this thread is essential. Coming back to this for sure.